- tert-Leucine-ADB-CHMINACA
- DMBA-CHMINACA
- (2S)-2-{[1-(Cyclohexylmethyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoic acid
- N-[1-(Cyclohexylmethyl)-1H-indazole-3-carbonyl]-3-methyl-L-valine
EMCDDA. Report on the risk assessment of N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA), European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2018. 1.1 MB. #tert-Leucine-ADB-CHMINACA
Wouters, E; Mogler, L; Cannaert, A; Auwärter, V; Stove, C. Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L‐valine or L‐ tert ‐leucine. Drug Test. Anal., 1 Aug 2019, 11 (8), 1183–1191. 1.4 MB. https://doi.org/10.1002/dta.2607 #13
Wagmann, L; Stiller, RG; Fischmann, S; Westphal, F; Meyer, MR. Going deeper into the toxicokinetics of synthetic cannabinoids: In vitro contribution of human carboxylesterases. Arch. Toxicol., 1 Nov 2022, 96 (10), 2755–2766. 1.6 MB. https://doi.org/10.1007/s00204-022-03332-z #DMBA-CHMINACA